CLOs on the Move

Ovid Therapeutics

www.ovidrx.com

 
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.ovidrx.com
  • 1460 Broadway
    New York, NY USA 10036
  • Phone: 646.661.7661

Executives

Name Title Contact Details
Thomas Perone
Senior Vice President, General Counsel and Corporate Secretary Profile

Similar Companies

Development Centers Inc

Development Centers Inc is a Detroit, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

New Wave Surgical

New Wave Surgical is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Dedicated Phase 1

Dedicated Phase 1 is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Johns Hopkins Bayview Medical

Johns Hopkins Bayview Medical is a Baltimore, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Therabody

A deep muscle massage treatment unlike anything you’ve ever felt. Feel better, move better, and recover faster with tension and soreness relief. Therabody